Skip Navigation



Cardiovascular Research Advance Access [Accepted Manuscript] published online on June 19, 2008
Cardiovascular Research, doi:10.1093/cvr/cvn170
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
80/1/106    most recent
cvn170v2
cvn170v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by de Miguel, L. S.
Right arrow Articles by Battegay, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Miguel, L. S.
Right arrow Articles by Battegay, E. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

B2 kinin receptor plays a key role in B1-, ACE inhibitor-, and VEGF- stimulated in vitro angiogenesis in the hypoxic mouse heart

Lourdes Sanchez de Miguel1,5, Shiva Neysari1,5, Sonja Jakob1, Marco Petrimpol1, Nicole Butz1, Andrea Banfi2, Christian E. Zaugg3, Rok Humar1,4 and Edouard J. Battegay1,4

1 Department of Biomedicine Vascular Biology University Hospital, CH-4031 Basel, Switzerland
2 Department of Biomedicine Cell and Gene Therapy University Hospital, CH-4031 Basel, Switzerland
3 Department of Biomedicine Cardiology, University Hospital, CH-4031 Basel, Switzerland
4 Division of Internal Medicine, University Hospital, CH-8091 Zürich, Switzerland

Correspondence: Edouard Battegay, MD Division of Internal Medicine University Hospital CH-8091 Zürich, Switzerland Tel: ++41 44 255 2400 Fax:++41 44 255 4426 Email: Edouard.Battegay{at}usz.ch

Aims: Angiotensin converting enzyme (ACE) inhibition reduces heart disease and vascular stiffness in hypertension and leads to kinin accumulation. In this study, we analyzed the role and importance of two kinin receptor subtypes in angiogenesis during ACE inhibition in an in vitro model of angiogenesis of the mouse heart.

Methods and Results: First, we analyzed the angiogenic properties of bradykinin and enalapril on wild-type C57Bl/6 and B2 receptor-/- mouse heart under normoxia (21% O2) and hypoxia (1% O2) in vitro and the contribution of B1 and B2 kinin receptors to this effect. Bradykinin induced dose-dependent endothelial sprout formation in vitro in adult mouse heart only under hypoxia (1.7 fold, n = 6, p < 0.05). The B2 receptor mediated sprouting that was induced by bradykinin and vascular endothelial growth factor (VEGF164; n = 6, p < 0.05) but did not mediate sprouting that was induced by growth factors bFGF or PDGF-BB. Enalapril induced sprouting through both the B1 and B2 kinin receptors, but it required the presence of the B2 receptor in both scenarios and was dependent on BK synthesis. B1-receptor agonists induced sprout formation via the B1 receptor (2.5 fold, n = 6, p < 0.05), but it required the presence of the B2 receptor for them to do so. Both B2-receptor and B1-receptor agonist-induced angiogenesis required nitric oxide biosynthesis.

Conclusion: The kinin B2 receptor plays a crucial role in angiogenesis that is induced by different vasoactive molecules, namely bradykinin, ACE inhibitors, B1-stimulating kinin metabolites, and VEGF164 in an in vitro model of angiogenesis of mouse heart under hypoxia. Therapeutic treatment of hypertensive patients by using ACE inhibitors may potentially benefit the ischemic heart through inducing B2-dependent heart neovascularization.

Time for primary review: 20 days

5 These authors contributed equally to the manuscript


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Bader
Kallikrein-Kinin System in Neovascularization
Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 617 - 619.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.